Related Experiment Videos
Positron emission tomographic (PET) studies in dementia
I Goto1, T Taniwaki, S Hosokawa
1Department of Neurology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Journal of the Neurological Sciences
|January 1, 1993
Summary
Positron emission tomographic (PET) studies reveal that various dementias, including Alzheimer
Area of Science:
- Neuroscience
- Medical Imaging
Background:
- Dementia encompasses a spectrum of neurodegenerative disorders characterized by cognitive decline.
- Parkinson's disease, while primarily a movement disorder, can also present with cognitive impairment.
- Understanding regional brain metabolism differences is crucial for diagnosing and differentiating these conditions.
Purpose of the Study:
- To investigate regional cerebral glucose metabolism patterns in various dementia subtypes and Parkinson's disease.
- To differentiate dementia with and without Parkinson's disease using metabolic imaging.
- To correlate metabolic changes with neuronal dysfunction and cell death in neurodegenerative diseases.
Main Methods:
- Positron emission tomography (PET) was utilized to measure regional cerebral glucose metabolism.
- Studies were conducted on patients diagnosed with Alzheimer-type dementia, Pick's disease, Huntington's disease, Creutzfeldt-Jakob's disease, and Parkinson's disease (with and without dementia).
- Healthy normal controls were included for comparison.
Main Results:
- Alzheimer-type dementia showed reduced metabolism in frontal, temporal, parietal, sensory-motor, and striatal regions.
- Pick's disease exhibited decreased metabolism in frontal and temporal areas.
- Parkinsonian patients with dementia had widespread reductions across frontal, temporal, parietal, occipital, sensory-motor, and striatal regions.
- Huntington's disease revealed reduced metabolism in frontal, parietal, and striatal areas.
- Creutzfeldt-Jakob's disease demonstrated marked hypometabolism throughout all brain regions.
- Parkinson's disease without dementia showed no significant reductions in cerebral glucose metabolism.
Conclusions:
- Distinct patterns of regional cerebral glucose hypometabolism are observed in different dementia types.
- Cerebral glucose hypometabolism is a hallmark of dementia, potentially indicating neuronal dysfunction and cell death.
- PET imaging of glucose metabolism can aid in differentiating neurodegenerative conditions.